2026-07-01T11:26:22-07:00 2024-12-31 262176601 EASY OFFICE DBA JITASA 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 990 2024-01-01 814011501 PATIENTS FOR AFFORDABLE DRUGS PATI 2027347555 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 CHARLES HURLEY TREASURER 2027347555 2026-07-01 1 1 JEREMY CORK P01544850 2082874777 2026-07-01 2024 2025-03-06 01:10:19Z X DAVID MITCHELL 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 2630590 0 X www.patientsforaffordabledrugs.org X 2016 MD PATIENTS FOR AFFORDABLE DRUGS IS THE ONLY NATIONAL PATIENT ADVOCACY ORGANIZATION FOCUSED EXCLUSIVELY ON LOWERING PRESCRIPTION DRUG PRICES. WE EMPOWER AND MOBILIZE PATIENTS AND ALLIES, HOLD ACCOUNTABLE THOSE IN POWER, AND FIGHT TO SHAPE AND ACHIEVE SYSTEM-CHANGING POLICIES THAT MAKE PRESCRIPTION DRUGS AFFORDABLE FOR ALL PEOPLE IN THE UNITED STATES. 4 4 9 4 0 0 1461976 1643681 40000 0 40 29 816001 986880 2318017 2630590 0 0 0 0 1160090 1083116 0 0 0 458609 924326 1618699 2007442 699318 623148 1271094 2131080 107763 319573 1163331 1811507 THE PURPOSE OF PATIENTS FOR AFFORDABLE DRUGS IS TO PROMOTE HEALTH BY RAISING THE VOICES OF PATIENTS AND THEIR FAMILIES ON THE CAUSES OF HIGH DRUG PRICES AND TO HELP EDUCATE THEM ABOUT HOW THEY CAN BE A PART OF THE DISCUSSION AND WORK TO MAKE REFORMS TO THE US SYSTEM OF DRUG PRICING IN THE PRIVATE AND PUBLIC SECTORS. 0 0 1654852 0 0 GENERAL PROGRAM: THE GENERAL PROGRAM CONSISTS OF BUILDING A PATIENT-CENTERED COMMUNITY THAT IS FINANCIALLY INDEPENDENT FROM ANY GROUP THAT PROFITS FROM THE DEVELOPMENT OR DISTRIBUTION OF PRESCRIPTION DRUGS. WE EDUCATE THE PUBLIC, PATIENTS, AND KEY STAKEHOLDERS ABOUT THE CHALLENGES THAT PEOPLE FACE UNDER THE CURRENT DRUG DEVELOPMENT AND PRICING FRAMEWORK. 75842 0 0 WEST HEALTH 2023 PILOT RECRUITMENT PROJECT: GRASSROOTS RECRUITMENT AND OUTREACH STRATEGY WITH AN EMPHASIS ON IDENTIFYING AND ENGAGING PATIENTS FROM COMMUNITIES WHO ARE DISPROPORTIONATELY HARMED BY HIGH DRUG PRICES. 60000 0 0 THE HOPEWELL FUND - IMPACT PROJECT: A GENERAL SUPPORT GRANT WITH A FOCUS ON RECRUITMENT AND TRAINING OF PATIENTS IN COLORADO, MICHIGAN AND VIRGINIA WHO TAKE HIGH COST PRESCRIPTION MEDICATION. 0 0 0 1790694 1 1 0 0 0 0 0 0 0 0 1 0 0 1 1 1 1 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 1 0 0 0 1 8 0 1 9 1 0 0 0 0 0 0 0 0 0 0 0 0 X 4 4 0 0 0 0 0 0 0 1 1 0 0 1 0 0 0 1 1 0 X X EASY OFFICE DBA JITASA 2082874777 1120 S RACKHAM WAY SUITE 300 MERIDIAN ID 83642 MERITH BASEY EXECUTIVE DIRECTOR 28 12 X 237297 0 8794 WENDY CHEW CHIEF OPERATING OFFICER 28 12 X 196359 0 22789 TEMI AMOYE COMMUNITY ORGANIZING AND ADVOCACY DIRECTOR 28 12 X 129667 0 5262 EMMA SANDS DIRECTOR OF MEDIA AND COMMUNICATIONS 28 12 X 119376 0 5140 ALYSON BANCROFT DIRECTOR OF LEGISLATION, POLICY AND ALLIANCES 28 12 X 42388 0 1846 DAVID MITCHELL PRESIDENT/FOUNDER 28 12 X X 0 0 0 CAL LAROCHE TREASURER 0.25 X X 0 0 0 CHARLES HURLEY BOARD MEMBER 0.25 X 0 0 0 TOMI FADEYI-JONES BOARD MEMBER 0.25 X 0 0 0 725087 0 43831 4 0 1 0 TRILOGY INTERACTIVE LLC PO BOX 4177 MOUNTAIN VIEW CA 940404177 STRATEGIC CONSULTING 124625 FAIRMARK PARTNERS LLP 1825 7TH STREET NW SUITE 821 WASHINGTON DC 20001 LEGAL SERVICES 110000 FIREHOUSE STRATEGIES LLC 1501 M STREET NW SUITE 1100 WASHINGTON DC 20005 STRATEGIC CONSULTING 110000 3 0 0 0 0 0 1643681 0 1643681 0 29 0 0 29 0 0 0 0 0 0 0 0 0 0 0 0 0 REVENUE FROM REIMBURSEMENT (RELATED ORGANIZATION) 900099 986863 986863 0 0 17 17 0 0 986880 2630590 986880 0 29 516291 482862 33429 450875 450875 26664 23111 3553 20149 2028 18121 69137 67958 1179 111201 111201 190529 185284 5245 339322 338931 391 20941 17564 3377 9274 9274 145449 4215 141234 67908 66244 1664 1918 1918 2433 2198 235 7550 924 6626 TELEPHONE & TELECOMMUNICATIONS 9129 9129 0 0 TRAINING 8468 6817 1651 0 RECRUITING 7307 7307 0 0 OTHER 2897 2854 43 0 2007442 1790694 216748 0 660210 1025867 28756 28785 455000 637500 6359 6993 20279 13921 3075 6358 117694 425577 1271094 2131080 107763 40900 278673 107763 319573 X 718331 1811507 445000 0 1163331 1811507 1271094 2131080 623148 0 0 0 25028 0 X 0 1 X 1 0 X 874759 578328 1453409 1461976 1643681 6012153 874759 578328 1453409 1461976 1643681 6012153 1808331 4203822 1629 95 54 40 29 1847 574850 816001 986880 2377731 8391731 65000 0.50095 0.18264 X Schedule A, Part II, Line 10 REVENUE FROM REIMBURSEMENT (RELATED ORGANIZATION). RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 0 0 0 0 0 0 0 0 0 0 0 0 20279 13921 6358 0 0 0 0 6358 LEASE ROU ASSET 266502 DUE FROM C4 159075 425577 LEASE LIABILITIES - ROU 278673 278673 X 2630590 0 0 0 0 0 2630590 0 0 0 2630590 2007442 0 0 0 0 0 2007442 0 0 0 2007442 Schedule D, Part X, Line 2 THE ACCOUNTING STANDARD ON ACCOUNTING FOR UNCERTAINTY IN INCOME TAXES ADDRESSES THE DETERMINATION OF WHETHER TAX BENEFITS CLAIMED OR EXPECTED TO BE CLAIMED ON A TAX RETURN SHOULD BE RECORDED IN THE FINANCIAL STATEMENTS. UNDER THAT GUIDANCE, THE ORGANIZATION MAY RECOGNIZE THE TAX BENEFIT FROM AN UNCERTAIN TAX POSITION ONLY IF IT IS MORE LIKELY THAN NOT THAT THE TAX POSITION WILL BE SUSTAINED ON EXAMINATION BY TAXING AUTHORITIES BASED ON THE TECHNICAL MERITS OF THE POSITION. THE TAX BENEFITS RECOGNIZED IN THE FINANCIAL STATEMENTS FROM SUCH A POSITION ARE MEASURED BASED ON THE LARGEST BENEFIT THAT HAS A GREATER THAN 50 PERCENT LIKELIHOOD OF BEING REALIZED UPON ULTIMATE SETTLEMENT. THERE WERE NO UNRECOGNIZED TAX BENEFITS IDENTIFIED OR RECORDED AS LIABILITIES FOR FISCAL YEAR 2024. THE ORGANIZATION FILES FORM 990 IN THE U.S. FEDERAL JURISDICTION. THE ORGANIZATION IS GENERALLY NO LONGER SUBJECT TO EXAMINATION BY THE INTERNAL REVENUE SERVICE FOR YEARS BEFORE 2020. 0 0 0 0 0 0 0 0 0 MERITH BASEY EXECUTIVE DIRECTOR 237297 0 0 0 0 0 0 0 8794 0 246091 0 0 0 WENDY CHEW CHIEF OPERATING OFFICER 196359 0 0 0 0 0 0 0 22789 0 219148 0 0 0 Form 990, Header, Line B THE AMENDED FORM 990 IS BEING FILED TO CORRECT THE REPORTING ON SCHEDULES A AND B. IN THE ORIGINALLY FILED RETURN, A CONTRIBUTION RECEIVED THROUGH FIDELITY CHARITABLE WAS REPORTED AS A DONATION FROM ARNOLD VENTURES. THE AMENDED RETURN UPDATES THE DONOR INFORMATION TO PROPERLY REFLECT FIDELITY CHARITABLE AS THE DONOR AND CORRECTS THE PUBLIC SUPPORT PERCENTAGE CALCULATION ON SCHEDULE A. Form 990, Part VI, Section B, Line 11b THE FORM 990 DRAFT IS SHARED WITH THE BOARD MEMBERS VIA EMAIL. Form 990, Part VI, Section B, Line 15 THE EXECUTIVE DIRECTOR'S COMPENSATION WAS REVIEWED AND APPROVED BY THE FOUNDER, DAVID MITCHELL. ALL STAFF THAT REPORTS TO THE EXECUTIVE DIRECTOR HAS THEIR COMPENSATION REVIEWED AND APPROVED BY THE EXECUTIVE DIRECTOR WHO CONSULTED WITH THE FOUNDER FOR COMPENSATION DECISIONS. Form 990, Part VI, Section C, Line 19 THE FORM 990 IS MADE AVAILABLE TO THE PUBLIC VIA GUIDESTAR.ORG AND IRS.GOV WEBSITES. GOVERNING DOCUMENTS ARE MADE AVAILABLE TO THE PUBLIC UPON REASONABLE REQUEST. PATIENTS FOR AFFORDABLE DRUGS NOW 1155 15TH ST N W SUITE 500 WASHINGTON DC 20005 823044855 MOBILIZE PATIENTS TO SUPPORT LEGISLATION TO LOWER DRUG PRICES. DC 501(c)(4) N/A N/A 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 PATIENTS FOR AFFORDABLE DRUGS NOW o 849123 ACTUAL COST PATIENTS FOR AFFORDABLE DRUGS NOW n 137740 ACTUAL COST